Analysts have raised their earnings per share estimates for Gossamer Bio, Inc. for the first quarter of 2023. (NASDAQ:GOSS)
A biotechnology business with the ticker symbol "GOSS" is called Gossamer Bio, INC In a research study made public on ...
Tag: GOSS, Analyst Rating
Brokerages have assigned a consensus rating of “Hold” to Gossamer Bio, Inc. (NASDAQ:GOSS).
According to the data that Bloomberg.com provided, the fourteen rating agencies presently keeping an eye on Gossamer Bio, INC (NASDAQ: ...
Gossamer Bio, Inc. (NASDAQ:GOSS) short interest falls by 6.7%.
Gossamer Bio, INC (NASDAQ: GOSS) saw a sizeable drop in borrowed shares during January. Since January 15th, the number of ...
Victory Capital Management Inc. purchased 47,450 shares of Gossamer Bio, Inc. (NASDAQ:GOSS).
According to Victory Capital Management INC's most recent Form 13F filing with the Securities and Exchange Commission, the increase in ...
DekaBank Deutsche Girozentrale has purchased shares of Gossamer Bio, Inc. (NASDAQ:GOSS).
The most recent report submitted to the Securities and Exchange Commission (SEC) reveals that during the third quarter, DekaBank Deutsche ...
Brokerages have given Gossamer Bio, Inc. (NASDAQ:GOSS) a consensus rating of “Moderate Buy.”
According to the data made available by Bloomberg.com, the thirteen investment firms actively following the company have collectively given the ...
Brokerages have given Gossamer Bio, Inc. (NASDAQ:GOSS) an average rating of “Moderate Buy.”
According to Bloomberg, the stock has been given a " moderate-buy " recommendation among the fourteen analysts currently covering Gossamer ...
Short interest in Gossamer Bio, Inc. (NASDAQ:GOSS) increased 12.2% in November.
The number of short positions in Gossamer Bio, Inc. increased throughout November, as evidenced by the percentage of total short ...